Document is current
Any future updates will be listed below
-
Authors
Becker Aarseth, Erling https://orcid.org/0009-0007-9828-7685
Jareid, Ine
Demmo-Bru, Christine
Rønning, Stine Dagsberg https://orcid.org/0009-0008-8692-8075
Ringheim, Inge https://orcid.org/0000-0002-3283-2333
-
Funding
Funding for this research was provided by:
Vestfold Hospital Trust
- License Information
-
More Information
Article History
Received: 2 July 2025
Revised: 20 March 2026
Accepted: 16 April 2026
First Online: 28 April 2026
Declarations
:
: ClinicalTrials.gov (NCT06045741) on 2023-09-13
: This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. The study was approved by Regional Committee for Medical Research Ethics South-East Norway (REK 487258).
: The authors affirm that human research participants provided informed consent for publication. All participants (including clinicians) provided written informed consent for participation and publishing, including description of potential adverse effects of VR treatment.
: Inge Ringheim and Stine Dagsberg Rønning declare that they have no competing interests. Erling Becker Aarseth, Ine Jareid and Christine Demmo-Bru have ownership in the company that developed the VR software solution used in this study. There was no contact with authors and included patients during the study.
